Terms: = Prostate cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
133 results:
1. Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic prostate cancers.
Shevach JW; Candelieri-Surette D; Lynch JA; Hubbard RA; Alba PR; Glanz K; Parikh RB; Maxwell KN
J Natl Compr Canc Netw; 2024 Apr; 22(4):237-243. PubMed ID: 38631387
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of an imageless machine-learning algorithm for the initial screening of prostate cancer.
Martelin N; De Witt B; Chen B; Eschwège P
Prostate; 2024 Jun; 84(9):842-849. PubMed ID: 38571454
[TBL] [Abstract] [Full Text] [Related]
3. Triple Primary cancers: An Analysis of Genetic and Environmental Factors.
Borja NA; Silva-Smith R; Calfa C; Sussman DA; Tekin M
Cancer Prev Res (Phila); 2024 May; 17(5):209-215. PubMed ID: 38361103
[TBL] [Abstract] [Full Text] [Related]
4. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
5. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
[TBL] [Abstract] [Full Text] [Related]
6. Vegetarian diets and risk of all-cause mortality in a population-based prospective study in the United States.
Blackie K; Bobe G; Takata Y
J Health Popul Nutr; 2023 Nov; 42(1):130. PubMed ID: 37996932
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.
Zhang Z; Cai Q; Wang J; Yao Z; Ji F; Hang Y; Ma J; Jiang H; Yan B; Zhanghuang C
Sci Rep; 2023 Oct; 13(1):17719. PubMed ID: 37853026
[TBL] [Abstract] [Full Text] [Related]
8. 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder cancer: United States insurance claims data.
Del Giudice F; Belladelli F; Glover F; Basran S; Li S; Mulloy E; Pradere B; Soria F; Krajewski W; Nair R; Muncey W; Seranio N; Eisenberg ML
World J Urol; 2023 Oct; 41(10):2783-2791. PubMed ID: 37548746
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
[TBL] [Abstract] [Full Text] [Related]
10. Visual Analogue Scale and Expanded prostate cancer Index Composite-26 in the Evaluation of Urinary Continence Recovery After Three-Dimensional Laparoscopic Radical prostatectomy, a Single-Center Prospective Registered Study.
Valli J; Haapiainen H; Murtola TJ; Huhtala H; Kaipia A; Raitanen M
Urology; 2023 Jul; 177():103-108. PubMed ID: 37146729
[TBL] [Abstract] [Full Text] [Related]
11. Are high-risk prostate cancer patients being treated equally? The impact of PSA.
Kord E; Ferenczi B; DiNatale RG; Daily A; Koenig H; Frankel J; Jung N; Flores JP; Porter C
Urol Oncol; 2023 Apr; 41(4):204.e17-204.e25. PubMed ID: 36918337
[TBL] [Abstract] [Full Text] [Related]
12. cancer survival in the northwestern of São Paulo State, Brazil: A population-based study.
Mafra A; Bardot A; Charvat H; Weiderpass E; Soerjomataram I; Fregnani JHTG
Cancer Epidemiol; 2023 Apr; 83():102339. PubMed ID: 36863216
[TBL] [Abstract] [Full Text] [Related]
13. A comprehensive gene expression profile analysis of prostate cancer cells resistant to paclitaxel and the potent target to reverse resistance.
Che P; Jiang S; Zhang W; Zhu H; Hu D; Wang D
Hum Exp Toxicol; 2022; 41():9603271221129854. PubMed ID: 36165000
[No Abstract] [Full Text] [Related]
14. Association between prior cancer diagnosis and osteoporosis: a matched case-control study.
Yang S; Wang N; Wang J; Lix LM; Leslie WD; Yuan B
Arch Osteoporos; 2022 Aug; 17(1):112. PubMed ID: 35960383
[TBL] [Abstract] [Full Text] [Related]
15. Retzius-Sparing
Turkolmez K; Akpinar C; Kubilay E; Suer E
J Endourol; 2022 Sep; 36(9):1214-1222. PubMed ID: 35546454
[No Abstract] [Full Text] [Related]
16. Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.
Wu B; Shen P; Yin X; Yu L; Wu F; Chen C; Li J; Xu T
Br J Clin Pharmacol; 2023 Feb; 89(2):440-448. PubMed ID: 35349180
[TBL] [Abstract] [Full Text] [Related]
17. Application of Shear Wave Elastography and Contrast-Enhanced Ultrasound in Transrectal prostate Biopsy.
Sharen GW; Zhang J
Curr Med Sci; 2022 Apr; 42(2):447-452. PubMed ID: 35301673
[TBL] [Abstract] [Full Text] [Related]
18. Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer.
Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
Prostate; 2022 May; 82(6):740-750. PubMed ID: 35226380
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With cancer in the United States.
Hawley JE; Sun T; Chism DD; Duma N; Fu JC; Gatson NTN; Mishra S; Nguyen RH; Reid SA; Serrano OK; Singh SRK; Venepalli NK; Bakouny Z; Bashir B; Bilen MA; Caimi PF; Choueiri TK; Dawsey SJ; Fecher LA; Flora DB; Friese CR; Glover MJ; Gonzalez CJ; Goyal S; Halfdanarson TR; Hershman DL; Khan H; Labaki C; Lewis MA; McKay RR; Messing I; Pennell NA; Puc M; Ravindranathan D; Rhodes TD; Rivera AV; Roller J; Schwartz GK; Shah SA; Shaya JA; Streckfuss M; Thompson MA; Wulff-Burchfield EM; Xie Z; Yu PP; Warner JL; Shah DP; French B; Hwang C;
JAMA Netw Open; 2022 Jan; 5(1):e2142046. PubMed ID: 34982158
[TBL] [Abstract] [Full Text] [Related]
20. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy.
Tan YG; Fang AHS; Lim JKS; Khalid F; Chen K; Ho HSS; Yuen JSP; Huang HH; Tay KJ
Prostate; 2022 Feb; 82(3):298-305. PubMed ID: 34855228
[TBL] [Abstract] [Full Text] [Related]
[Next]
